Related Experiment Videos
Palliative pelvic exenteration: patient selection and results
1Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
Oncology (Williston Park, N.Y.)
|April 1, 1996
Summary
Total pelvic exenteration, a major surgery for extensive pelvic cancer, is now also used for symptom relief. Careful patient selection is key to improving quality of life for those with advanced pelvic tumors.
Area of Science:
- Oncology
- Surgical Oncology
- Palliative Care
Background:
- Total pelvic exenteration (TPE) is a radical surgical procedure for advanced pelvic malignancies.
- Historically, high morbidity and mortality limited TPE to curative-intent cases.
- Improved surgical outcomes have expanded TPE indications to palliative settings.
Purpose of the Study:
- To evaluate the expanded role of TPE in managing locally extensive pelvic malignancy.
- To assess the efficacy of TPE in palliating symptoms associated with pelvic tumors.
- To highlight the importance of patient selection for palliative TPE.
Main Methods:
- Review of surgical outcomes and indications for TPE.
- Analysis of preoperative evaluation protocols for palliative TPE candidates.
- Assessment of symptom control and quality of life post-palliative TPE.
Main Results:
- TPE is increasingly utilized for palliative symptom management (pain, obstruction, fistulas, bleeding).
- Careful preoperative assessment is crucial for identifying suitable candidates.
- Appropriately selected patients experience significant symptom palliation and improved quality of life.
Conclusions:
- Total pelvic exenteration can effectively palliate symptoms in selected patients with advanced pelvic cancer.
- The procedure offers a viable option for improving quality of life when curative treatment is not feasible.
- Rigorous patient selection is paramount for successful palliative TPE outcomes.